Clinical Trial Update: BPaL(M) Regimen for the Treatment of MDR/RR-TB [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for the BPaL(M) regimen targeting multidrug- and rifampicin-resistant tuberculosis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug- and Rifampicin-resistant Tuberculosis

Snippet

Sponsor: Asan Medical Center | Conditions: Multidrug- and Rifampicin-resistant Tuberculosis | Phase 4 | Status: RECRUITING